Accessibility Tools

In the News

Top 10 HIV Clinical Developments of 2023

It is inevitable that in a not-too-distant future, most people with HIV who live in richer nations will control their infection with medications that emerge from the end of a needle.

Read more

Are we winning the war on AIDS?

New HIV infection rates are falling, and treatments are improving. But do we have the political will to end HIV/AIDS?

Dallas Voice talked with Bryan King of North Texas Infectious Disease Consultants.

Read more

Lenacapavir for HIV-1 — Potential Promise of a Long-Acting Antiretroviral Drug

The Research Department at North Texas ID Consultants is proud to be listed in the New England Journal of Medicine as collaborators with this new, and exciting long acting antiretrovirals for the treatment of HIV. We are currently enrolling in other studies using long acting medications for the treatment of HIV. If you are interested in one of our clinical trials you can contact the research department through our website at under the research section.

Read more

You will need the Adobe Reader to view and print these documents. Get Adobe Reader